Roche’s Evrysdi approved by European Commission as first and only at home treatment for spinal muscular atrophy

NEXT STORY
Novartis expands targeted radioligand therapy pipeline with in-license for compounds targeting Fibroblast Activation Protein (FAP)
PREV STORY
Reata Pharmaceuticals Announces Presentations at Upcoming Medical Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

National Health Plans Select Inovalon’s Integrated Platform

BOWIE, Md., July 17, 2017 (GLOBE NEWSWIRE) -- Inovalon (NASDAQ:INOV), a leading technology company ...

author_avatar
NASDAQ Market News

Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer

SAINT-GENIS-POUILLY, France, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” ...

author_avatar
NASDAQ Market News

Celldex Provides Corporate Update and Reports Third Quarter 2018 Results

HAMPTON, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...

author_avatar
NASDAQ Market News